Seizures as an early symptom of autosomal dominant Alzheimer's disease.


Journal

Neurobiology of aging
ISSN: 1558-1497
Titre abrégé: Neurobiol Aging
Pays: United States
ID NLM: 8100437

Informations de publication

Date de publication:
04 2019
Historique:
received: 20 06 2018
revised: 01 11 2018
accepted: 25 11 2018
pubmed: 8 1 2019
medline: 18 12 2019
entrez: 8 1 2019
Statut: ppublish

Résumé

Our objective was to assess the reported history of seizures in cognitively asymptomatic mutation carriers for autosomal dominant Alzheimer's disease (ADAD) and the predictive value of seizures for mutation carrier status in cognitively asymptomatic first-degree relatives of ADAD patients. Seizure occurrence in the Dominantly Inherited Alzheimer Network observational study was correlated with mutation carrier status in cognitively asymptomatic subjects. Of 276 cognitively asymptomatic individuals, 11 (4%) had experienced seizures, and nine of these carried an ADAD mutation. Thus, in the Dominantly Inherited Alzheimer Network population, seizure frequency in mutation carriers was significantly higher than in noncarriers (p = 0.04), and the positive predictive value of seizures for the presence of a pathogenic mutation was 81.8%. Among cognitively asymptomatic ADAD family members, the occurrence of seizures increases the a priori risk of 50% mutation-positive status to about 80%. This finding suggests that ADAD mutations increase the risk of seizures.

Identifiants

pubmed: 30616208
pii: S0197-4580(18)30424-X
doi: 10.1016/j.neurobiolaging.2018.11.022
pmc: PMC6572755
mid: NIHMS1008072
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18-23

Subventions

Organisme : Medical Research Council
ID : MR/L023784/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L023784/2
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : P50 AG005142
Pays : United States
Organisme : NIA NIH HHS
ID : UF1 AG032438
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

J Neuropathol Exp Neurol. 2001 Dec;60(12):1137-52
pubmed: 11764087
Curr Opin Neurol. 2003 Apr;16(2):165-70
pubmed: 12644744
Epilepsia. 2004 Jul;45(7):751-6
pubmed: 15230697
Epilepsia. 2006 May;47(5):867-72
pubmed: 16686651
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):210-6
pubmed: 17132964
Brain. 2010 Apr;133(Pt 4):1143-54
pubmed: 20375137
Nat Neurosci. 2010 Jul;13(7):812-8
pubmed: 20581818
Epilepsy Behav. 2011 May;21(1):20-2
pubmed: 21501974
Epilepsia. 2012 Mar;53(3):399-404
pubmed: 22242702
N Engl J Med. 2012 Aug 30;367(9):795-804
pubmed: 22784036
Arch Neurol. 1990 Aug;47(8):847-50
pubmed: 2375689
Epilepsia. 2014 Apr;55(4):475-82
pubmed: 24730690
Neurology. 2014 Jul 15;83(3):253-60
pubmed: 24928124
Neuroscience. 2015 Feb 12;286:251-63
pubmed: 25484360
Alzheimer Dis Assoc Disord. 2016 Apr-Jun;30(2):186-92
pubmed: 26756385
Epileptic Disord. 2016 Mar;18(1):1-12
pubmed: 26907471
Philos Trans R Soc Lond B Biol Sci. 2016 Aug 5;371(1700):
pubmed: 27377723
Neurology. 2016 Aug 30;87(9):912-9
pubmed: 27466472
Ann Neurol. 2016 Dec;80(6):858-870
pubmed: 27696483
Lancet Neurol. 2016 Dec;15(13):1317-1325
pubmed: 27777020
Lancet Neurol. 2016 Dec;15(13):1326-1335
pubmed: 27777022
Nat Med. 2017 Jun;23(6):678-680
pubmed: 28459436
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
Neuroreport. 1996 Jul 8;7(10):1582-4
pubmed: 8904759

Auteurs

Jonathan Vöglein (J)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Department of Neurology, Ludwig-Maximilians-Universität München, München, Germany.

Soheyl Noachtar (S)

Department of Neurology, Ludwig-Maximilians-Universität München, München, Germany.

Eric McDade (E)

Washington University School of Medicine, Saint Louis, MO, USA.

Kimberly A Quaid (KA)

Department of Medical and Molecular Genetics, Indiana University, Indianapolis, IN, USA.

Stephen Salloway (S)

Butler Hospital, Providence, RI, USA.

Bernardino Ghetti (B)

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

James Noble (J)

Columbia University, New York, NY, USA.

Sarah Berman (S)

University of Pittsburgh, Pittsburgh, PA, USA.

Jasmeer Chhatwal (J)

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Hiroshi Mori (H)

Osaka City University Medical School, Asahi Machi, Abenoku, Osaka, Japan.

Nick Fox (N)

Dementia Research Centre, Institute of Neurology, University College London, London, UK.

Ricardo Allegri (R)

FLENI, Buenos Aires, Argentina.

Colin L Masters (CL)

Florey Institute, University of Melbourne, Parkville, Victoria, Australia.

Virginia Buckles (V)

Washington University School of Medicine, Saint Louis, MO, USA.

John M Ringman (JM)

Center for the Health Professionals, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.

Martin Rossor (M)

Dementia Research Centre, Institute of Neurology, University College London, London, UK.

Peter R Schofield (PR)

Neuroscience Research Australia, Randwick, New South Wales, Australia; School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.

Reisa Sperling (R)

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Mathias Jucker (M)

German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Hertie Institute of Clinical Brain Research, University of Tübingen, Tübingen, Germany.

Christoph Laske (C)

German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.

Katrina Paumier (K)

Washington University School of Medicine, Saint Louis, MO, USA.

John C Morris (JC)

Washington University School of Medicine, Saint Louis, MO, USA.

Randall J Bateman (RJ)

Washington University School of Medicine, Saint Louis, MO, USA.

Johannes Levin (J)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Department of Neurology, Ludwig-Maximilians-Universität München, München, Germany. Electronic address: johannes.levin@med.uni-muenchen.de.

Adrian Danek (A)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Department of Neurology, Ludwig-Maximilians-Universität München, München, Germany. Electronic address: adrian.danek@med.uni-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH